New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cresco Labs Inc.
CRLBF
Shape
US Flag

PNK

Unprofitable

Unprofitable

761M

Drug Manufacturers - Specialty & Generic

Next Earning date - 08 Nov 2024

761M

Drug Manufacturers - Specialty & Generic

Next Earning date - 08 Nov 2024

1.71USD
Shape0.01 ( 0.59%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-80%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

35%

Quote Panel

Shape
Updated October 24, 2024
1W 7.55 % 1M 2.40 % 3M 8.92 % 1Y 21.28 %

Key Metrics

Shape
  • Market Cap

    761.32M


  • Shares Outstanding

    445.22M


  • Share in Float

    440.12M


  • Dividende

    0


  • Earning Date

    08 Nov 2024


  • Price Target

    1.71


  • Average Volume

    478132


  • Beta

    1.974


  • Range

    1.055-2.65


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.crescolabs.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.99x

P/S Ratio

1.24x

P/B Ratio

1.1

Debt/Equity

-22.7%

Net Margin

$-0.5

EPS

How CRLBF compares to sector?

P/E Ratio

Relative Strength

Shape

CRLBF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$788M

Shape328%

2025-Revenue

$0.03

Shape121%

2025-EPS

$87M

Shape77%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cowen & Co.

downgrade

Previous: Not converted

2022-12-20

Now: Market Perform

Wedbush

initialise

Previous: Not converted

2022-12-02

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.03
vs 0.07

Q4.22

arrow
arrow

N/A

-0.03
vs -0.05

Q1.23

arrow
arrow

N/A

-0.09
vs -0.09

Q2.23

arrow
arrow

N/A

-0.05
vs -0.05

Q3.23

arrow
arrow

N/A

-0.04
vs -0.03

Q4.23

arrow
arrow

+133%

0.01
vs -0.03

Q1.24

arrow
arrow

N/A

-0.02
vs -0.09

Q2.24

arrow
arrow

N/A

-0.16
vs -0.05

Q3.24

arrow
arrow

+121%

0.01
vs -0.04

Q4.24

arrow
arrow

+45%

0.01
vs 0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-2%

210.5M  vs 215.5M

Q4.22

arrow
arrow

-8%

199.6M  vs 217.8M

Q1.23

arrow
arrow

-9%

194.2M  vs 214.4M

Q2.23

arrow
arrow

-9%

197.9M  vs 218.2M

Q3.23

arrow
arrow

-9%

190.6M  vs 210.5M

Q4.23

arrow
arrow

-3%

193.4M  vs 199.6M

Q1.24

arrow
arrow

-6%

183.5M  vs 194.2M

Q2.24

arrow
arrow

-7%

184.3M  vs 197.9M

Q3.24

arrow
arrow

-2%

186M  vs 190.6M

Q4.24

arrow
arrow

-1%

191M  vs 193.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

0%

-0.00
vs -0.01

Q4.22

arrow
arrow

-29%

-0.29
vs -0.00

Q1.23

arrow
arrow

-5%

-0.05
vs -0.29

Q2.23

arrow
arrow

-6%

-0.06
vs -0.05

Q3.23

arrow
arrow

-27%

-0.27
vs -0.06

Q4.23

arrow
arrow

+1%

0.01
vs -0.27

Q1.24

arrow
arrow

-1%

-0.01
vs 0.01

Q2.24

arrow
arrow

-12%

-0.12
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

16

16
vs 16

NA

Q4.22

arrow
arrow

13

13
vs 16

-19%

Q1.23

arrow
arrow

13

13
vs 13

NA

Q2.23

arrow
arrow

15

15
vs 13

15%

Q3.23

arrow
arrow

12

12
vs 15

-20%

Q4.23

arrow
arrow

10

10
vs 12

-17%

Q1.24

arrow
arrow

8

8
vs 10

-20%

Q2.24

arrow
arrow

9

9
vs 8

13%

Earnings Growth

Latest News

CRLBF

marijuanastocks.com

8 hours ago